Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: FEBS J. 2019 Jun 21;286(20):4036–4059. doi: 10.1111/febs.14954

Table 4.

Rhamnolipid congener pattern observed upon expression of the RhlAPa-A182P/RhlBPa variant with respect to RhlAPa-WT/RhlBPa in a BGR1ΔrhlA background.

Variant C8 (%)* C10 (%)* C12 (%)*
RhlAPa-WT 5.4 (± 0.6) 74.3 (± 0.6) 20.3 (± 0.6)
RhlAPa-A182P 7.9 (± 0.6) 65.1 (± 1.1) 27.0 (± 1.3)
*

Fatty acid contribution were calculated from LC/MS negative mode analysis of congeners C8-C8 (m/z 301.3), Rha-C8-C8 (m/z 447.3), Rha-Rha-C8-C8 (m/z 593.5), C8-C10/C10-C8 (m/z 329.3), Rha-C8-C10/Rha-C10-C8 (m/z 475.4), Rha-Rha-C8-C10/Rha-Rha-C10-C8 (m/z 621.6), C10-C10 (m/z 357.3), Rha-C10-C10 (m/z 503.4), Rha-Rha-C10-C10 (m/z 649.5), C10-C12/C12-C10 (m/z 385.3), Rha-C10-C12/Rha-C12-C10 (m/z 531.4), Rha-Rha-C10-C12/Rha-Rha-C12-C10 (m/z 677.5), C12-C12 (m/z 413.6), Rha-C12-C12 (m/z 559.7), and Rha-Rha-C12-C12 (m/z 705.5). No others congeners longer than C12 were detected.